324 related articles for article (PubMed ID: 6224627)
1. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
Russo J; Russo ME
Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
Machka K; Dickert H; Braveny I
Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
[TBL] [Abstract][Full Text] [Related]
3. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
Eliopoulos GM; Moellering RC
Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
[TBL] [Abstract][Full Text] [Related]
4. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
Weingärtner L; Sitka U; Patsch R; Thiemann HH
Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
[TBL] [Abstract][Full Text] [Related]
5. Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactions.
Fortner CL; Finley RS; Schimpff SC
Pharmacotherapy; 1982; 2(6):287-99. PubMed ID: 6220262
[TBL] [Abstract][Full Text] [Related]
6. Procedural compliance and clinical outcome associated with therapeutic interchange of extended-spectrum penicillins.
Martin LA; Watkins JB; Greene SA; Haddow AD; Gerecht WB; Powell CW
Am J Hosp Pharm; 1990 Jul; 47(7):1551-4. PubMed ID: 2368746
[TBL] [Abstract][Full Text] [Related]
7. Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination.
Wildfeuer A; Schmalreck A; Räder K; Eibel G; Pfaff G
Arzneimittelforschung; 1989 Jan; 39(1):94-100. PubMed ID: 2785802
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
Høiby N; Bremmelgaard A; Schouenborg P
Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
[TBL] [Abstract][Full Text] [Related]
9. Third-generation cephalosporins: a critical evaluation.
Barriere SL; Flaherty JF
Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
Gootz TD; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
[TBL] [Abstract][Full Text] [Related]
11. The acylampicillins: mezlocillin, piperacillin, and azlocillin.
Drusano GL; Schimpff SC; Hewitt WL
Rev Infect Dis; 1984; 6(1):13-32. PubMed ID: 6369480
[TBL] [Abstract][Full Text] [Related]
12. Overview of acylureidopenicillin pharmacokinetics.
Bergan T
Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mezlocillin and carbenicillin as therapy for various infectious diseases.
Rolandi E; Barreca T; Ragni N; Valente U; Sannia A; Fontana I; Magnani G; Salvini P
Clin Ther; 1981; 4(4):321-5. PubMed ID: 6460558
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
[TBL] [Abstract][Full Text] [Related]
15. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
Thabaut A; Durosoir JL; Saliou P
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
[TBL] [Abstract][Full Text] [Related]
16. Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Holmes B; Richards DM; Brogden RN; Heel RC
Drugs; 1984 Nov; 28(5):375-425. PubMed ID: 6391888
[TBL] [Abstract][Full Text] [Related]
17. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
Quentin C; Sageaux JC; Bebear C; Latrille J
Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of piperacillin therapy for infection.
Pancoast S; Prince AS; Francke EL; Neu HC
Arch Intern Med; 1981 Oct; 141(11):1447-50. PubMed ID: 6456708
[TBL] [Abstract][Full Text] [Related]
19. The extended-spectrum penicillins: microbiologic, utilization, and cost review in a community hospital.
Stein GE; VanderLinde J; Mummaw N; Leader I; Sugarman B
Hosp Pharm; 1989 Sep; 24(9):701-4. PubMed ID: 10295542
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Fass RJ
Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
